ProSciento Overview: Clinical R&D Services for Metabolic Diseases

About this Fact Sheet

ProSciento is a global clinical research organization, exclusively focused on drug and device development programs for diabetes, NASH, obesity and related metabolic diseases. Building on nearly two decades of experience and more than 350 completed metabolic clinical projects, ProSciento provides customized clinical research services for multinational clinical trial programs. Our scalable R&D service model incorporates therapeutic expertise, advanced methodologies, patient access strategies, and global operational excellence to provide our clients an unique advantage in today’s rapidly evolving landscape of metabolic drug and device development.